* BIO-Key International Inc BKYI.OQ reported a quarterly
adjusted loss of 13 cents per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 11 cents per share.
* Revenue rose 37.7% to $1.30 million from a year ago; analysts
expected $1.50 million.
* The mean earnings estimate of analysts had fallen by
about 266.7% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BIO-Key International Inc shares had fallen by 13.1% this
quarter and lost 13.1% so far this year.
* The company reported a quarterly loss of $1.02 million.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $6.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 16 at 12:59 a.m.
All figures in US dollars unless otherwise stated